This suggests that FSCN1 may play a key role in PIK3CA-altered tumor cells and that the survival of PIK3CA-altered tumor cells under radiotherapy treatment may be specifically accompanied by high expression of the FSCN1 gene. The gene discussed is PIK3CA; the disease is neoplasm.